Regulatory and Economic Aspects in Oncology

Addresses key issues relating to the increasing expenditure on new targeted cancer therapies. Discusses the evaluation of benefits, harms, and costs. Examines drug pricing and drug price regulation in different countries. Explores the changing landscape in marketing authorization and its regulation.